Jan 7, 2026 08:02AM
Jan 7, 2026 08:00AM
Mar 7, 2022 12:00PM
Mar 7, 2022 12:00PM
Mar 4, 2022 08:01AM
Mar 4, 2022 08:00AM
Mar 1, 2022 11:35AM Immunicom Appoints Jennifer Haldeman as Vice President of Commercial Operations
Feb 28, 2022 08:00AM
Feb 15, 2022 08:00AM
Jan 19, 2022 09:12AM
Jan 19, 2022 05:53AM
Jan 19, 2022 01:00AM
Dec 21, 2021 08:03AM
Dec 21, 2021 08:00AM Zogenix Submits New Drug Application for FINTEPLA® (Fenfluramine) in Japan for the Treatment of Epileptic Seizures Associated with Dravet Syndrome
Dec 20, 2021 08:00AM
Dec 16, 2021 04:05PM
Dec 2, 2021 04:16PM
Dec 1, 2021 08:03AM
Dec 1, 2021 08:00AM
Nov 17, 2021 04:05PM
Nov 11, 2021 04:05PM Zogenix to Participate in Two Upcoming Investor Conferences
Nov 4, 2021 04:05PM
Nov 1, 2021 08:00AM
Oct 21, 2021 08:00AM
Oct 19, 2021 08:00AM
Sep 30, 2021 08:04AM
Sep 30, 2021 08:00AM
Sep 28, 2021 12:00PM Needham & Company Reiterates Buy Rating on Zogenix, Inc. (ZGNX) as Fintepla LGS sNDA Submitted
Sep 28, 2021 08:02AM
Sep 28, 2021 08:00AM
Sep 16, 2021 05:39PM
Aug 26, 2021 08:01AM
Aug 26, 2021 08:00AM
Aug 16, 2021 05:01PM
Aug 5, 2021 04:01PM Zogenix Provides Corporate Update and Reports Second Quarter 2021 Financial Results
Aug 3, 2021 04:05PM
Jul 22, 2021 08:00AM
Jul 21, 2021 08:00AM
Jun 21, 2021 08:00AM
May 24, 2021 08:38AM
May 11, 2021 04:01PM
May 6, 2021 04:03PM Zogenix (ZGNX) Tops Q1 EPS by 2c, Revenues Beat
May 6, 2021 04:01PM
Apr 27, 2021 08:00AM
Apr 22, 2021 08:01AM
Apr 22, 2021 08:00AM
Apr 16, 2021 08:00AM
Apr 8, 2021 08:00AM
Mar 25, 2021 08:00AM Zogenix to Participate in the Stifel 3rd Annual CNS Day
Mar 2, 2021 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All